Methimazole embryopathy: a contribution to defining the phenotype

Area of Science:

• Endocrinology
• Teratology
• Genetics

Background:

• Prenatal exposure to methimazole, an antithyroid drug, has been associated with potential developmental abnormalities.
• The precise phenotype of methimazole embryopathy remains incompletely defined, necessitating further case reports and studies.

Observation:

• A patient presented with a distinct set of facial features, including upward slanted palpebral fissures, arched eyebrows, and a broad nasal bridge.
• The patient also exhibited developmental delay and radio-ulnar synostosis.
• Maternal exposure to methimazole during pregnancy was confirmed, with no other etiological factors identified.

Findings:

• The observed features align with previously reported characteristics of methimazole embryopathy.
• The addition of radio-ulnar synostosis expands the known spectrum of anomalies associated with this condition.
• This case underscores the importance of considering methimazole exposure in the differential diagnosis of congenital malformations.

Implications:

• Further research is needed to fully delineate the phenotype and long-term outcomes of methimazole embryopathy.
• This case highlights the critical role of detailed maternal and prenatal histories in diagnosing congenital anomalies.
• Understanding these teratogenic effects can inform clinical management and genetic counseling for pregnant individuals using methimazole.